Introdução: Nódulos regenerativos multiacinares são nódulos hepatocelulares benignos relacionados com alterações vasculares hepáticas. São muito semelhantes à hiperplasia nodular focal mas ocorrem num contexto diferente de doença hepática crónica. O objectivo deste trabalho foi descrever os achados imagiológicos principais destes nódulos e compará-los com um grupo controlo de hiperplasia nodular focal. Material e Métodos: Foi efectuada uma revisão cega de estudos por ressonância magnética de 26 casos de nódulos regenerativos multiacinares e 25 de hiperplasia nodular focal, sendo os dois grupos comparados quanto à dimensão das lesões, morfologia, margens, estrutura, aspecto em T1, T2, difusão e após contraste (incluindo na fase hepatobiliar), presença de cicatriz central e halo hipointenso. Resultados: Foram encontradas diferenças significativas entre nódulos regenerativos multiacinares e hiperplasia nodular focal quanto às dimensões das lesões (mediana 2,35 cm AIQ: 2,13 vs 6,00 cm AIQ: 5,20 respectivamente, p < 0,001), presença de halo hipointenso após contraste (n = 9 vs n = 2, p = 0,038) e de cicatriz central (n = 9 vs n = 20, p = 0,002 The purpose of the present study was to describe the key imaging features of these lesions and compare them with a control arm of focal nodular hyperplasia. Material and Methods: A blinded consensus review of liver magnetic resonance consisting of 26 cases of multiacinar regenerative nodules and 25 cases of focal nodular hyperplasia was performed. Lesion size, shape, margins, structure, T1 and T2 signal intensity, diffusion and contrast-enhanced features (including hepatobiliary phase), presence of a central scar and of a peripheral hypointense rim were compared between the two groups.
INTRODUCTION
Apart from cirrhosis and inflammation, other liver injuries can produce different types of hepatocellular nodules. The International Working Party has classified these lesions into hyperplastic and dysplastic nodules, according to two primary sets of criteria, the cell type and the histological pattern of the surrounding liver. [1] [2] [3] [4] \Hyperplastic or regenerative nodules are well-defined regions of normal liver parenchyma that have enlarged in response to a stimulus, especially from vascular origin, but also due to necrosis or other kind. 2, 3, 5 They are further subdivided into monoacinar or multiacinar nodules, cirrhotic regenerative nodules and focal nodular hyperplasia (FNH). 5 Multiacinar regenerative nodules (MRN), also called large regenerative nodules, are frequently grouped together with nodular regenerative hyperplasia (NRH), although the latter is an example of the monoacinar type, with minute micronodular transformation of a whole or part of the liver. 1, 3 MRN involve more than one portal tract and, attaining macroscopic dimensions (between 5 mm and 5 cm), are easily detected on cross-sectional imaging. 1 MRN have been alternatively coined FNH-like lesions, because they strongly resemble FNH, both in imaging studies and histopathologically. [6] [7] [8] They have been described in BuddChiari syndrome and other vascular liver disorders. 2, 9, 10 An increased incidence in long time cancer survivors previously treated by chemo or radiotherapy, especially paediatric patients, has also been described, and the mechanism seems to be related to the non-selective effect of chemotherapy regimens in the non-tumorous liver. [11] [12] [13] Particularly, the use of oxaliplatin-based compounds has been associated with such FNH-like lesions.
14 Disturbance of the liver microcirculation with reduced portovenous or hepatovenous flow may result in a compensatory arterial hyperperfusion, ultimately leading to a nonspecific polyclonal focal hepatocyte proliferation and MRN formation. 2, 6, 11, 15 Some authors have linked all these benign hepatocellular nodules, namely NRH, MRN and FNH, to a common congenital anomaly of the portal tract. 16 The present study aimed to focus at the description of the key imaging features of MRN in particular those that may preclude a wrong diagnosis of simple FNH. This distinction is clinically relevant since recognition of MRN may trigger further efforts to identify an underlying liver disease, especially of vascular origin, contrarily to the diagnosis of FNH, which is considered an incidental finding in an otherwise normal liver. 1, 2, 17 Multiplicity of lesions has been reported as suggestive of underlying vascular diseases. 18 Other differences have been reported, such as T1 hyperintensity and T2 hypointensity of MRN lesions, absence of the central scar or a hypodense/intense rim. 2, 9, 17, 19 Furthermore, MRN should be differentiated from malignant liver lesions, especially metastases in the case of follow up of oncologic patients. 14, 15 
MATERIAL AND METHODS Patient selection and standard of reference
From the medical records of two large tertiary care hospitals, a search was conducted from the years 2008 to 2016. Cases containing the diagnosis of FNH and/or regenerative hyperplasia in the radiological report were retrieved. The database contained 26 cases of liver nodules reported as FNH-like in patients with an underlying liver disease (Table 1) . Twenty-five consecutive cases of FNH in an otherwise healthy liver were included for comparative purposes. Diagnosis of MRN and FNH was established by histological analysis (n = 13 and n = 6, respectively) or by imaging criteria (n = 13 and n = 19, respectively). Histological analysis was performed by percutaneous biopsy (n = 8 cases of MRN and n = 3 cases of FNH), surgical biopsy (n = 1 case of MRN) or surgical specimen analysis (n = 4 cases of MRN, n = 3 cases of FNH), according to established criteria. Imaging criteria for the diagnosis of MRN consisted in the demonstration of a FNH-like nodule on MR imaging, showing temporal stability (minimum follow-up time of two years) and exclusively detected in the clinical context of a known underlying liver disease. A FNH diagnosis was made in all cases where the typical FNH MR imaging criteria were found in an otherwise healthy patient. These include: lesion homogeneity except for the central scar; slightly different signal from the liver parenchyma on T1 and T2 sequences; strong homogeneous arterial enhancement becoming similar to the liver on the portal and delayed phases after contrast; presence of a central scar which is hypointense on pre-contrast T1, hyperintense on T2 and enhancing in the delayed phase; lack of capsule and possible lobulated contours. An additional feature is the uptake of liver-specific contrast on the hepatobiliary phase. 18, [20] [21] [22] All procedures performed were in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Due to the retrospective nature of this study, with pre-existing data, formal informed consent was not required.
Image analysis
Two experienced radiologists at each centre (with more Revista Científica da Ordem dos Médicos www.actamedicaportuguesa.com than 10 years of abdominal sub-speciality practice), blinded to the diagnosis and clinical history, performed a consensus reading of the MR exams. Only one lesion per case, the largest one that could be depicted alone, was evaluated. MR examinations were performed according to the institutions' protocols using two magnet field strengths of 1.5 and 3T and multichannel phased-array coils. All studies included gradient-echo (GRE) in/opposed phase T1-weighted (T1-w) (TR 100 ms, TE 2.27 and 5.19 ms, flip angle 70º, matrix 256x192, FOV 380 mm, slice thickness 8 mm for 1.5T; TR 4.36 ms, TE 1.32 and 2.46 ms, flip angle 9º, matrix 320x224, FOV 380 mm, slice thickness 4 mm for 3T) and fast spin-echo fat saturated (FS) T2-w sequences (TR 1550 ms, TE 93 ms, flip angle 150º, matrix 384x269, FOV 380 mm, slice thickness 8 mm for 1.5T; TR 5700 ms, TE 88 ms, flip angle 150º, matrix 320x300, FOV 380 mm, slice thickness 5 mm for 3T), as well as 3D GRE FS T1-w sequences (TR 4.88 ms, TE 2.38 ms, flip angle 10º, matrix 256x205, FOV 380 mm, slice thickness 3 mm for 1.5T; TR 3.78 ms, TE 1.38 ms, flip angle 11º, matrix 320x168, FOV 400 mm, slice thickness 2.5 mm for 3T) for contrastenhanced (CE) MR after the intravenous bolus injection of extracellular gadolinium chelates or hepatobiliary chelates (Gd-EOB-DTPA, gadoxetic acid) in the late arterial phase, portal venous phase, late venous/ transitional phase (180 s after injection) and hepatobiliary phase (20 min after injection). Diffusion weighted imaging (DWI) with at least two b values (50-150, 600-800 s/mm2) was available in most studies (24 cases of FNH and 17 cases of MRN) (TR 2300 ms, TE 70 ms, flip angle 90º, matrix 160x120, FOV 450 mm, slice thickness 8 mm for 1.5T; TR 6276 ms, TE 68 ms, flip angle 90º, matrix 142x112, FOV 380 mm, slice thickness 6 mm for 3T).
Lesion size, shape (round/oval/lobulated), margins (well/ill-defined), structure (homogeneous/heterogeneous), presence of microscopic or macroscopic fatty content, haemorrhage and/or necrosis were recorded and analysed. T1 and T2 signal intensity (SI) and qualitative evaluation of diffusion-weighted imaging (presence/absence of restriction to diffusion) were registered. In the CE-MR study, lesions were classified according to their relative intensity to the surrounding liver parenchyma observed in the late arterial, portal and delayed/transitional phase after injection of extra-cellular Gd-chelates or gadoxetic acid, respectively. Uptake of the hepatobiliary contrast agent (gadoxetic acid) was considered to be present in cases of complete or partial nodular iso/hyperintensity compared to the liver parenchyma (22 cases of FNH and 18 cases of MRN). Detection of a hypoenhancing peripheral rim and central scar were also registered. 
Statistical analysis
The median size of MRN and FNH lesions in the imaging exams was calculated together with the interquartile range (IQR). Also, in the MRN subgroup developing after chemotherapy, the median time from the start of the treatment to the time of detection by imaging exams was determined. Comparative analysis between the MRN group and the FNH group were performed with SPSS v.20. Comparison of the continuous variable dimension between both groups was conducted using Mann-Whitney U test and comparison of categorical variables between both groups was conducted using Fisher's exact test. In categorical variables with three values, characteristics were grouped together for comparison, according to the previously described imaging characteristics of MRN: T1-w SI features were grouped as hyperintense versus non-hyperintense (iso/hypointense); T2-w SI as hypointense versus non-hypointense (iso/ hyperintense); CE-MR evaluation as hyperenhancing versus non-hyperenhancing (iso/hypoenhancing) in the late arterial phase and as washout positive (hypoenhancing) or washout negative (iso/hyperenhancing) in the portal phase. Statistical significance was considered for a p value < 0.05.
RESULTS
Twelve cases of MRN were detected in postchemotherapy patients. The time from the start of the treatment to the diagnosis was registered in nine cases, corresponding to a median of 5 years (IQR: 9).
Of the remaining 14 cases of MRN, 10 were detected in the context of non-cirrhotic portal hypertension and two in patients with vascular malformations (Table 1) .
The median size of FNH lesions was 6.00 cm (IQR: 5.20) while the median size of MRN was 2.35 cm (IQR: 2.13), which was significantly smaller (U = 98.50, p < 0.001). The majority of lesions in both groups were round or oval, with well-defined borders and homogeneous structure. None of the FNH lesions displayed haemorrhage or necrosis. Only one case of MRN showed evidence of partial necrosis but none had evidence of haemorrhage. Regarding T1-w SI, two (8%) FNH lesions showed T1 hyperintensity, (including one with microscopic fat content determined by MR), contrarily to five MRN (19%), however the association between T1 hyperintensity and the type of nodule was not significant. None of the T1-w hyperintense MRN had macroscopic or microscopic fat components. T2-w SI analysis showed that the majority of FNH and MRN were hyper to isointense but 
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Revista Científica da Ordem dos Médicos www.actamedicaportuguesa.com six MRN lesions and one FNH disclosed T2-w hypointensity, but the relation was not significant (p = 0.099; Fig.1 portal and/or delayed phases. The majority of lesions in both groups (FNH = 25; MRN = 21) were hypervascular in the late arterial phase without washout in the portal phase. In cases where gadoxetic acid was administered (22 FNH and 18 MRN cases) contrast uptake (considered equal or higher than the adjacent normal parenchyma in the hepatobiliary phase) was seen at a similar visual rate. The association between the presence of a hypointense rim and the type of nodule, MRN or FNH, was significant as was the relation with the presence of a central scar (p = 0.038 and p = 0.002, respectively). Readers were able to detect a hypointense rim at the CE-MR in nine MRN and two FNH lesions, and a central scar in 20 FNH lesions (80%) and nine MRN lesions (35%) (Fig's. 2 and 3) .
The complete data of imaging characteristics in both types of nodules is summarized in Table 2 .
DISCUSSION
Although MRN is a benign hepatocellular nodule resembling FNH, the fact that MRN is linked to a potential vascular underlying abnormality of the liver makes its recognition clinically important, since further diagnostic work-up may take place. Also, when dealing with other clinical contexts such as cirrhosis or chemotherapy-treated patients, the differentiation from malignancy assumes special importance if one considers that it may appear as a "de novo" focal liver lesion on follow-up imaging studies. 2, 14, 15, 17 Our study has shown that, among all MR imaging features, there are two important differences for the discrimination between MRN and FNH: the presence of a central scar and of a hypointense peripheral rim detected at the contrast-enhanced study. MRN generally lack a central scar while this feature is shown on 80% of FNH, the reported MRI central scar detection rate. 20 Since MRN tended to be significantly smaller than FNH, this could explain the difference in the detection rate of the central scar but it should also be stressed that even larger MRN may not display this imaging feature. 6, 9, [22] [23] [24] The presence of a hypoenhancing rim is an important distinctive finding, present in 35% of MRN against only 8% of FNH. Also coined the halo sign, correlation with the pathological specimen, has showed the presence of peripheral sinusoidal dilatation and vascular congestion in the peri-nodular, atrophic and compressed parenchyma. 2, 19, 25, 26 Unfortunately, this interesting feature was only seen in less than half the cases of MRN, thus reducing its usefulness for the differential diagnosis between the two lesion types based on imaging alone.
These features may explain some cases of atypical FNH that occasionally lead to unnecessary invasive procedures to secure a diagnosis, such as biopsy or even liver resection, as displayed in this series.
Otherwise, like typical FNH, MRN are generally well-defined homogeneous nodules, without evidence of calcification, haemorrhage or necrosis. 9, 22 Although MRN were initially reported as having high T1-w SI and low to intermediate T2-w SI, there were no significant associations regarding SI in the current study. MRN were mostly T1-w isointense and T2-w iso-hyperintense. 1, 2, 9, 25 It has been reported that the MRN T1-w hyperintensity may be relative, due to the hypointensity of a surrounding abnormally congested liver. 6 We note, however, that in the present series there was no pathologic proof of liver congestion in the non-tumoural parenchyma. Other possible explanation for the T1-w hyperintense MRN is the presence of paramagnetic substances, such as copper. 1, 2 On the other hand, FNH T1-w hyperintensity may result from fatty replacement, one of the most common atypical findings reported for this entity. 20 As expected, DWI does not play a significant role in the differentiation of the two types of hepatocellular nodules. The SI of both FNH and MRN seen on high b-value DWI were furthermore similar to the surrounding liver parenchyma. [27] [28] [29] Concerning the CE-MR study, both categories of nodules behave similarly with brisk transitory enhancement in the late arterial phase and a predominant lack of washout in the subsequent phases. The hypervascular behaviour reflecting its increased arterial supply may be problematic for the distinction between MRN and HCC in the context of cirrhosis or, more rarely, with hypervascular liver metastases in the setting of oncologic follow-up. 2, 4, 14, 15, 30 Therefore, it is important to acknowledge the absence of washout in order to reinforce their benign origin, avoiding erroneous patient management. 2, 11, 17, 31 The absence of a correlate of this hypervascular lesion on the DWI is again in favour of MRN and against metastasis. 32, 33 As expected, all FNH and MRN nodules in our series showed contrast uptake in the hepatobiliary phase after gadoxetic acid administration similar or higher than the surrounding liver. This reflects their benign hepatocellular origin with preservation of the active membrane transport system via the surface receptors OATPB1/3, a feature that allows prompt discrimination from poorly differentiated HCC and liver metastases. 2, 34 This study has several limitations: the small number of patients, although fairly equivalent between both groups, may have affected the statistical significance of some comparisons. However, many studies in the literature have a similar number of cases of this infrequent type of liver nodule. 1, 2, 9, 30 Only one lesion per patient, considered the dominant lesion, was chosen, which implies the non-verified assumption of an equal behaviour among the multiple nodules in the same patient; not all cases were histologically proved especially among the MRN group. As previously explained the combination of imaging signs, together with the late uptake of hepatocyte-specific contrast agent in the specific clinical context of a non-healthy liver was used as an imperfect standard of reference. 9, 23, 30 Furthermore, the retrospective nature of the study did not allow verification of the real clinical usefulness concerning different choices for patient management.
Most published studies regarding MRN have focused on the distinction with malignant liver lesions occurring in the same clinical context. Comparison between MRN and FNH
